SRL
ABCL icon

Scientech Research LLC’s AbCellera Biologics ABCL Stock Holding History

Scientech Research LLC’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$121K Buy
+15,404
New +$75.3K 0.1% 171
2026
Q1 		– Sell
-18,988
Closed -$64.9K – 453
2025
Q4 		$64.9K Buy
+18,988
New +$84.8K 0.04% 437

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Scientech Research LLC's ABCL Position: Q2 2026 in Review

Scientech Research LLC opened a new position in AbCellera Biologics (ABCL) in Q2 2026: 15,404 shares worth $121K. The stake represents 0.1% of the portfolio and ranks #171 among its holdings. This is a return to the name: Scientech Research LLC previously reported a position in ABCL as recently as Q4 2025.

Scientech Research LLC first reported a position in ABCL in Q4 2025 and has held it in 2 quarters since. 151 funds tracked by Wall St. Rank hold ABCL as of Q2 2026.

  • Scientech Research LLC held 15,404 shares of AbCellera Biologics worth $121K as of Q2 2026.
  • AbCellera Biologics was a new Scientech Research LLC position in Q2 2026.
  • AbCellera Biologics made up 0.1% of Scientech Research LLC's portfolio in Q2 2026, its #171 holding.
  • Scientech Research LLC first reported a position in AbCellera Biologics in Q4 2025 and has held it in 2 quarters since.
  • 151 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2026.

Based on Scientech Research LLC's 13F filing for Q2 2026, filed 14 Aug 2026.